Jonathan Sussman

34PUBLICATIONS
225CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Tumour immunologyPredictive and prognostic markersHaematological tumoursGenetic immunology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (34)

|Sep 10, 2026
A bispecific CD3×CD19 antibody for systemic lupus erythematosus: a phase 1 trial.

|Jun 12, 2026
Effector Vδ1 γδ T cells mediate anti-tumor immunity and are reprogrammed by imatinib in human gastrointestinal stromal tumor.

|Apr 02, 2026
Identification of CD74-positive antigen presenting glioma cells in primary human tumors and murine models of NF1 high-grade glioma.

Stephanie N Brosius, Jonathan H Sussman, Isabella A DiStefano

|Feb 11, 2026
CCR4 expression defines a targetable subset of T-cell acute lymphoblastic leukemia.

Jason Xu, Michael McCoy, Zachary Martinez

|Feb 08, 2026
Determinants of hyperinsulinism severity in children with Beckwith-Wiedemann syndrome.

Andrew M George, Aravind Viswanathan, Jonathan H Sussman

|Jan 10, 2026
Disparities in Non-Small Cell Lung Cancer (NSCLC) by Age, Sex, and Race: A Systematic Review and Meta-Analysis of Immune Checkpoint Inhibitor (ICI) Trials.

Maxim Yaskolko, Christopher Liu, Alexander Barsouk

Pageof 6

Frequent Collaborators

12 joint publications

Kai Tan

11 joint publications

Omar Elghawy

10 joint publications

David Trent Teachey

9 joint publications

Petri Pölönen